<?xml version="1.0" encoding="UTF-8"?>
<p id="p0270">Production of HCVcc is a robust system to generate infectious HCV in na√Øve cells (
 <xref rid="bb0885" ref-type="bibr">Kato et al., 2006</xref>, 
 <xref rid="bb1900" ref-type="bibr">Zhong et al., 2005</xref>). The anti-HCV activity of hundreds of compounds approved for a wide variety of indications was determined immunochemically with anti-HCV E2 antibody in 96-well plate format. Over thirty compounds displayed anti-HCV activities, most of which were directed against HCV entry (
 <xref rid="bb0565" ref-type="bibr">Gastaminza et al., 2010</xref>).
</p>
